Outcome of lupus renal disease in the past two decades: A report from China

APLAR Journal of Rheumatology

Volumn 9, Issue 4, 2006, Pages 347-352

  Lu, Liang Jing ^a   Zou, Yu Qiong ^a   Guo, Gui Mei ^a   Yuan, Bing ^a   Chen, Xiao Xiang ^a   Ye, Shuang ^a   Dai, Min ^a   Yang, Cheng De ^a   Bao, Chun De ^a   Gu, Yue Ying ^a   Chen, Shun Le ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Lupus; Nephritis; Renal survival

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; LEFLUNOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADOLESCENT; ADULT; ARTICLE; CHINA; CHRONICITY; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EARLY INTERVENTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KAPLAN MEIER METHOD; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; LOG RANK TEST; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TIME SERIES ANALYSIS; TREATMENT RESPONSE;

EID: 33751021357     PISSN: 02190494     EISSN: 14798077     Source Type: Journal    
DOI: 10.1111/j.1479-8077.2006.00238.x     Document Type: Article

References (12)

1. Bono L, Cameron JS, Hicks JA (1999) The very long-term prognosis and complications of lupus nephritis and its treatment. QJM 92, 211-8.
2. Tan EM, Cohen AS, Fries JF, et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25, 1271-7.
3. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35, 630-40.
4. Schwartz MM, Lan SP, Bernstein J, Hill GS, Holley K, Lewis EJ (1992) Role of pathology indices in the management of severe lupus glomerulonephritis. Lupus Nephritis Collaborative Study Group. Kidney Int 42, 743-8.
5. Martins L, Rocha G, Rodrigues A, et al. (2002) Lupus nephritis: A retrospective review of 78 cases from a single center. Clin Nephrol 57, 114-9.
6. Ward MM, Studenski S (1992) Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. Arch Intern Med 152, 2082-8.
7. Cameron JS (1999) Lupus nephritis. J Am Soc Nephrol 10, 413-24.
8. Lu CS, Ye RG, Sun L (1998) Survival probability and predictors of death in patients with lupus nephritis. Chin J Intern Med 37, 250-3.
9. Contreras G, Tozman E, Nahar N, Metz D (2005) Maintenance therapies for proliferative lupus nephritis: Mycophenolate mofetil, azathioprine and intravenous cyclophosphamide. Lupus 14, s33-8.
10. Austin HA III, Boumpas DT, Vaughan EM, Balow JE (1995) High-risk features of lupus nephritis. Importance of race and clinical and histological factors in 166 patients. Nephrol Dial Transplant 10, 1620-8.
11. Najafi CC, Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J (2001) Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int 59, 2156-63.
12. Houssiau FA, Vasconcelos C, D'Cruz D, et al. (2002) Immunosuppressive therapy in lupus nephritis: The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum 46, 2121-31.